Nobuhisa Ishikawa

7PUBLICATIONS
21CO-AUTHORS
Molecular targetsPacific Peoples cultural determinants of healthPredictive and prognostic markersRespiratory diseasesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 05, 2026
Pamufetinib (TAS-115) for chronic fibrosing interstitial lung diseases with a progressive phenotype: a double-blind, multicenter, phase 2b clinical trial.

|May 20, 2025
Sputum Microbiome, Potentially Pathogenic Organisms, and Clinical Outcomes in Japanese Patients with COPD and Moderate Airflow Limitation: The Prospective AERIS-J Study.

Kazuhiro Yatera, Zhang Wang, Yoko Shibata

|Oct 17, 2024
Efficacy of immune checkpoint inhibitors according to programmed cell death-ligand 1 expression in patients with non-small cell lung cancer and brain metastasis: A real-world prospective observational study.

Takeshi Masuda, Yukari Tsubata, Kojirou Hata

|Jan 23, 2024
Risk Factors for Bleeding Events in Japanese Patients with Advanced Lung Cancer: Data from the Rising-VTE/NEJ037 Study.

Keita Kawakado, Yukari Tsubata, Takamasa Hotta

|Feb 02, 2023
Dose reduction of docetaxel avoids the usage of pegfilgrastim in docetaxel plus ramucirumab therapy for recurrent nonsmall cell lung cancer.

Kosuke Hamai, Shinya Miyaka, Shinpei Tada

|Apr 30, 2022
Phase 2 study of first-line pembrolizumab monotherapy in elderly patients with non-small-cell lung cancer expressing high PD-L1.

Takeshi Masuda, Kazunori Fujitaka, Tomoko Suzuki

Pageof 2

Frequent Collaborators

2 joint publications

Takeshi Masuda

2 joint publications

Kosuke Hamai

2 joint publications

Yoshikazu Inoue

1 joint publications

Kakuhiro Yamaguchi